# Paclitaxel

NDC: 72205-062
Generic name: Paclitaxel
Labeler / Manufacturer: Novadoz Pharmaceuticals LLC
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: Abbreviated NDA (generic)
Dosage form: INJECTION, SOLUTION
Routes: INTRAVENOUS
Marketing started: 20200826

FDA application: ANDA213434

## Active ingredients

- PACLITAXEL: 6 mg/mL

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"72205-062"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=72205-062
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=4e1bf850-d616-4ff3-b62a-2057dddc3dfe